|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07C 217/74 | |
| C07C 215/64 | |||
| C07D 265/16 | |||
| C07B 59/00 |
| (11) | Number of the document | 2514740 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12176584.6 |
| Date of filing the European patent application | 2008-03-13 | |
| (97) | Date of publication of the European application | 2012-10-24 |
| (45) | Date of publication and mention of the grant of the patent | 2018-12-19 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 895049 P | 2007-03-15 | US | |
| 944399 P | 2007-06-15 | US |
| (72) |
Gant, Thomas G, US
Sepher, Sarshar, US
Woo, Soon Hyung, US
|
| (73) |
Auspex Pharmaceuticals, Inc.,
1090 Horsham Road, North Wales, PA 19454,
US
|
| (54) | DEUTERATED O-DESMETHYLVENLAFAXINES WITH SEROTONINERGIC AND/OR NOREPINEPHRINERGIC ACTIVITY |
| DEUTERATED O-DESMETHYLVENLAFAXINES WITH SEROTONINERGIC AND/OR NOREPINEPHRINERGIC ACTIVITY |